PharmacoEconomics

, Volume 9, Issue 5, pp 382–391 | Cite as

Treatment of Traveller’s Diarrhoea

Economic Aspects
  • Mike A. Thomson
  • Ian W. Booth
Leading Article

Summary

Traveller’s diarrhoea (TD) is an enteric infective disease seen in 30 to 50% of the 30 million people who travel annually from the developed world to developing countries. It is the commonest disorder affecting international travellers. Although usually trivial, a significant minority of patients may develop a more protracted disease with an attendant increase in morbidity. This may then incur financial costs to the travellers themselves and to the healthcare systems of the host and origin countries.

Advice regarding risk avoidance has so far proved ineffective in altering the behaviour of travellers and consequently the incidence of TD among them. Hard data are lacking on the cost effectiveness and cost benefit of prophylaxis and treatment of TD. Thus, we have attempted to quantify, as far as is possible, the total cost of TD and to set this against the potential savings from avoiding TD if prophylaxis or treatment options were universally employed. It must be noted that the financial benefit-cost ratio of an intervention may not be the most suitable measure of its desirability. However, such concepts as the success of travel are inherently difficult to quantify in economic terms. This analysis applies to travellers from the UK and economic variations between countries will affect the outcomes obtained.

Nevertheless, given these necessary constraints, all possible treatment options have a more favourable benefit-cost ratio than prophylaxis. In conclusion, the case for prophylaxis is not strong except in selected high risk groups, and limited self-treatment seems economically justified.

Keywords

Diarrhea Cholera Acute Diarrhea Tropical Sprue Oral Cholera Vaccine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gorbach SL, Kean BH, Evans DG, et al. Travelers’ diarrhea and toxigenic Escherichia coli. N Engl J Med 1975; 292: 933–6PubMedCrossRefGoogle Scholar
  2. 2.
    Lee JA, Kean BH. International conference on the diarrhea of travelers — new directions in research: a summary. J Infect Dis 1978; 137:355–69CrossRefGoogle Scholar
  3. 3.
    MacDonald KL, Cohen ML. Epidemiology of travelers’ diarrhea: current perspectives. Rev Infect Dis 1986; 8: S117–21PubMedCrossRefGoogle Scholar
  4. 4.
    Merson MH, Morris GK, Sack DA, et al. Travelers’ diarrhea in Mexico: a prospective study of physicians and family members attending a congress. N Engl J Med 1976; 294: 1299–305PubMedCrossRefGoogle Scholar
  5. 5.
    Lindenbaum J. Malabsorption during and after acute intestinal infection. BMJ 1965; 2: 326–9PubMedCrossRefGoogle Scholar
  6. 6.
    Cook GC. Aetiology and pathogenesis of post-infective malabsorption (tropical sprue). Lancet 1984; I: 721–3CrossRefGoogle Scholar
  7. 7.
    Case records of the Massachusetts General Hospital. N Engl J Med 1992; 327: 182–91CrossRefGoogle Scholar
  8. 8.
    Fung WP, Monteiro WH, Ang HB, et al. Ulcerative postdysenteric colitis. Am J Gastroenterol 1972; 57: 341–8PubMedGoogle Scholar
  9. 9.
    Powell SJ, Wilmot AJ. Ulcerative post-dysenteric colitis. Gut 1966; 7: 438–43PubMedCrossRefGoogle Scholar
  10. 10.
    Giannella RA. Chronic diarrhea in travelers: diagnostic and therapeutic considerations. Rev Infect Dis 1986; 8: S223–6PubMedCrossRefGoogle Scholar
  11. 11.
    Gorbach SL. Travelers’ diarrhea. N Engl J Med 1982; 307: 881–3PubMedCrossRefGoogle Scholar
  12. 12.
    International Air Transport Association (IATA) International On-Flight Origin/Destination Statistics. Summary Report 1985. Geneva: IATA, 1986 May 27Google Scholar
  13. 13.
    DuPont HL. Modem views on travelers’ diarrhea (emporiatric enteritis). Trans R Soc Trop Med Hyg 1981; 75: 137–40CrossRefGoogle Scholar
  14. 14.
    Steffen R, Van der Linde F, Gyr K, et al. Epidemiology of diarrhea in travelers. JAMA 1983; 249: 1176–80PubMedCrossRefGoogle Scholar
  15. 15.
    Steffen R. Epidemiological studies of travelers’ diarrhea, severe gastrointestinal infections and cholera. Rev Infect Dis 1986; 8 Suppl. 2: S122–30PubMedCrossRefGoogle Scholar
  16. 16.
    Overseas travel and tourism. Business Monitor MA6, 1991. London: Government Statistical Service, Her Majesty’s Stationery Office, 1992: 19–20Google Scholar
  17. 17.
    Steffen R, Rickenbach M, Wilhelm U, et al. Health problems after travel to developing countries. J Infect Dis 1987; 156(1): 84–91PubMedCrossRefGoogle Scholar
  18. 18.
    Reid D, Dewar RD, Fallon RJ, et al. Infection and travel: the experience of package tourists and other travellers. J Infect 1980; 2: 365–70PubMedCrossRefGoogle Scholar
  19. 19.
    Kean BH. Turista in Teheran: travellers’ diarrhoea at the Eighth International Congresses of Tropical Medicine and Malaria. Lancet 1969; II: 583–4CrossRefGoogle Scholar
  20. 20.
    Hutchins P, Hindocha P, Phillips A, et al. Traveller’s diarrhoea with a vengeance in children of UK immigrants visiting their parental homeland. Arch Dis Child 1982; 57(3): 208–11PubMedCrossRefGoogle Scholar
  21. 21.
    DuPont HL, Haynes GA, Pickering LK, et al. Diarrhea of travelers to Mexico: relative susceptibility of United States and Latin American students attending a Mexican university. Am J Epidemiol 1977; 105: 37–41PubMedGoogle Scholar
  22. 22.
    Mooney G. Economic medicine and health care. 2nd ed. Harvester Wheatsheaf, 1992: 14–5Google Scholar
  23. 23.
    Samuelson PA. Economics. okyo: McGraw-Hill 1976: 5Google Scholar
  24. 24.
    Ericsson CD, DuPont HL. Travelers’ diarrhea: approaches to prevention and treatment. Clin Inf Dis 1993; 16: 616–26CrossRefGoogle Scholar
  25. 25.
    Chak A, Banwell JG. Traveler’s diarrhea. Gastroenterol Clin North Am 1993 Sep; 22(3): 549–61PubMedGoogle Scholar
  26. 26.
    Powell DW. Approach to the patient with diarrhea. In: Yamada T, Alpers DH, Owyang C, et al., editors. Textbook of gastroenterology. Philadelphia: JB Lippincott, 1991: 732Google Scholar
  27. 27.
    Black RE. Epidemiology of traveler’s diarrhea and relative importance of various pathogens. Rev Infect Dis 1990; 12(1): S73–9PubMedCrossRefGoogle Scholar
  28. 28.
    Mattila L, Siitonen A, Kyrönseppä H, et al. Seasonal variation in etiology of travelers’ diarrhea. J Infect Dis 1992; 165: 385–8PubMedCrossRefGoogle Scholar
  29. 29.
    Weber J. Cholera in the United States, 1965–1991: risks at home and abroad. Arch Intern Med 1994; 154: 551–6PubMedCrossRefGoogle Scholar
  30. 30.
    Taylor DN, Pollard RA, Blake PA. Typhoid in the United States and the risk to the international traveler. J Infect Dis 1983; 148: 599–602PubMedCrossRefGoogle Scholar
  31. 31.
    Bolivar R, Conkin RH, Vollet JJ, et al. Rotavirus in travelers’ diarrhea: study of an adult student population in Mexico. J Infect Dis 1978; 137: 324–7PubMedCrossRefGoogle Scholar
  32. 32.
    DuPont HL, Sanchez JF, Ericsson CD, et al. Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea. Am J Med 1990; 88 Suppl. 6A: 15S–9SPubMedCrossRefGoogle Scholar
  33. 33.
    Beubler E, Horina G. 5-HT2 and 5-HT3 receptor subtypes mediate cholera toxin-induced intestinal fluid secretion. Gastroenterology 1990; 99: 83–9PubMedGoogle Scholar
  34. 34.
    Black RE, Dykes AC, Anderson KE, et al. Handwashing to prevent diarrhea in day care centers. Am J Epidemiol 1981; 4: 945–51Google Scholar
  35. 35.
    Kozicki M, Steffen R, Schär M. ‘Boil it, peel it, cook it, or forget it’: does this rule prevent travelers’ diarrhea? Int J Epidemiol 1985; 14: 169–72PubMedCrossRefGoogle Scholar
  36. 36.
    Tjoa WS, DuPont HL, Sullivan P, et al. Location of food consumption and travelers’ diarrhea. Am J Epidemiol 1977; 106: 61–6PubMedGoogle Scholar
  37. 37.
    Kendrick MA. Summary of study on illness among Americans visiting Europe, March 31 1969–March 30 1970. J Infect Dis 1972; 126: 685–7PubMedCrossRefGoogle Scholar
  38. 38.
    Merson MH, Hughes JM, Lawrence DM, et al. Food- and waterborne disease outbreaks on passenger cruise vessels and aircraft. J Food Milk Technol 1976; 39: 285–8Google Scholar
  39. 39.
    Rosenberg ML, Koplan JP, Wachsmuth IK, et al. Epidemic diarrhea at Crater Lake from enterotoxigenic Escherichia coli: a large waterborne outbreak. Ann Intern Med 1977; 86: 714–8PubMedGoogle Scholar
  40. 40.
    Blake PA, Rosenberg ML, Florencia J, et al. Cholera in Portugal, 1974: II. Transmission by bottled mineral water. Am J Epidemiol 1977; 105: 344–8PubMedGoogle Scholar
  41. 41.
    Consensus Conference. Travelers’ diarrhea. JAMA 1985; 253: 2700–4CrossRefGoogle Scholar
  42. 42.
    DuPont HL. Nonfluid therapy and selected chemoprophylaxis of acute diarrhea. Am J Med 1985; 78 Suppl. 6B: 81–90CrossRefGoogle Scholar
  43. 43.
    DuPont HL. Prevention and treatment of traveler’s diarrhea. N Engl J Med 1993; 329(21): 1584–5CrossRefGoogle Scholar
  44. 44.
    Farthing MJ, DuPont HL, Guandalini S, et al. Treatment and prevention of traveller’s diarrhoea. Gastroenterol Int 1992; 5: 162–75Google Scholar
  45. 45.
    Bierer DW. Bismuth subsalicylate: its history, chemistry, and safety. Rev Infect Dis 1990; 12 Suppl. 1: S3–8PubMedCrossRefGoogle Scholar
  46. 46.
    DuPont HL, Ericsson CD, Johnson PC, et al. Use of bismuth subsalicylate for the prevention of travelers’ diarrhea. Rev Infect Dis 1990; 12 Suppl. 1: S64–7PubMedCrossRefGoogle Scholar
  47. 47.
    Murray BE. Resistance of Shigella, Salmonella, and other enteric pathogens to anti-microbial agents. Rev Infect Dis 1986; 8 Suppl. 2: S172–81PubMedCrossRefGoogle Scholar
  48. 48.
    Santosham M, Sack RB, Froehlich JL, et al. Biweekly prophylactic doxycycline for travelers’ diarrhea. J Infect Dis 1981; 143: 598–602PubMedCrossRefGoogle Scholar
  49. 49.
    Rademaker CM, Hoepelman IM, Wolfhagen MJ. Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers’ diarrhea. Eur J Clin Microbiol Infect Dis 1989; 8: 690–4PubMedCrossRefGoogle Scholar
  50. 50.
    Wiström J, Norrby SR, Burman LG, et al. Norfloxacin versus placebo for prophylaxis against travellers’ diarrhoea. J Anti-microb Chemother 1987; 20: 563–74CrossRefGoogle Scholar
  51. 51.
    Scott DA, Haberberger RL, Thornton SA, et al. Norfloxacin for the prophylaxis of travelers’ diarrhea in US military personnel. Am J Trop Med Hyg 1990; 42: 160–4PubMedGoogle Scholar
  52. 52.
    Back FT, Gaarslev K, Orskov V, et al. Mecillinam, a new prophylactic for tourists travelling to Egypt and the Far East. Scand J Infect Dis 1983; 15: 189–93Google Scholar
  53. 53.
    Taket CO, Losonsky G, Link H, et al. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N Engl J Med 1988; 318: 1240–3CrossRefGoogle Scholar
  54. 54.
    Hilpert H, Brussow H, Mietens C, et al. Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J Infect Dis 1987; 156: 158–65PubMedCrossRefGoogle Scholar
  55. 55.
    Centers for Disease Control. Health information for international travelers. MMWR Morb Mortal Wkly Rep 1983; 32 Suppl.: 70–1Google Scholar
  56. 56.
    Kantele A, Arvilommi H, Kantele JM, et al. Comparison of the human immune response to live oral, killed oral or killed parenteral Salmonella typhi TY21A vaccines. Microb Pathogen 1991; 10(2): 117–26CrossRefGoogle Scholar
  57. 57.
    Clemens JD, Sack DA, Harris JR, et al. Field trial of oral cholera vaccines in Bangladesh: result of one-year follow-up. J Infect Dis 1988; 158: 60–8PubMedCrossRefGoogle Scholar
  58. 58.
    Clemens JD, Sack DA, Harris JR, et al. Field trial of oral cholera vaccines in Bangladesh: result of three-year follow-up. Lancet 1990; 339: 270–3CrossRefGoogle Scholar
  59. 59.
    Peltola H, Siitonen A, Kyrönseppä H, et al. Prevention of travellers’ diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet 1991; 338: 1285–9PubMedCrossRefGoogle Scholar
  60. 60.
    Booth IW, Levine MM, Harries JT. Oral rehydration therapy in acute diarrhoea in childhood. J Ped Gastroenterol Nutr 1984; 3: 491–9CrossRefGoogle Scholar
  61. 61.
    WHO Diarrhoeal Disease Control Programme. Drugs in the management of acute diarrhoea in infants and young children. WHO/CDD/CMT/86.1. Rev. 1. Geneva: WHO, 1988Google Scholar
  62. 62.
    Ericsson CD, DuPont HL, Johnson PC. Non-antibiotic therapy for travelers’ diarrhea. Rev Infect Dis 1986; 8 Suppl. 2: S202–6PubMedCrossRefGoogle Scholar
  63. 63.
    Johnson PC, Ericsson CD, DuPont HL, et al. Comparison of loperamide with bismuth subsalicylate for the treatment of travelers’ diarrhea. JAMA 1988; 255: 757–60CrossRefGoogle Scholar
  64. 64.
    DuPont HL, Ericsson CD, Mathewson JJ, et al. Zaldaride maleate, an intestinal calmodulin inhibitor in the therapy of travelers’ diarrhea. Gastroenterology 1993; 104: 709–15PubMedGoogle Scholar
  65. 65.
    Choo V. UK revises indications for co-trimoxazole. Lancet 1995 Jul 15; 346: 175CrossRefGoogle Scholar
  66. 66.
    DuPont HL, Rêves RR, Galindo E, et al. Treatment of travelers’ diarrhea with trimethoprim-sulfamethoxazole alone. N Engl J Med 1982; 307: 841–4PubMedCrossRefGoogle Scholar
  67. 67.
    Ericsson CD, Johnson PC, DuPont HL, et al. Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers’ diarrhea. Ann Intern Med 1987; 106: 216–20PubMedGoogle Scholar
  68. 68.
    Salam I, Katelaris P, Leigh-Smith S, et al. Randomised trial of single-dose ciprofloxacin for travellers’ diarrhoea. Lancet 1994; 344: 1537–9PubMedCrossRefGoogle Scholar
  69. 69.
    Wiström J, Gentry L, Palmgren A-C, et al. Ecological effects of short-term ciprofloxacin treatment of travellers’ diarrhoea. J Antimicrob Chemother 1992; 30: 693–706PubMedCrossRefGoogle Scholar
  70. 70.
    Taylor D, Sanchez J, Candler W, et al. Treatment of travelers’ diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. Ann Intern Med 1991; 114: 731–4PubMedGoogle Scholar
  71. 71.
    Sack RB, Froehlich JL, Orskov F, et al. Doxycycline is an effective treatment for traveller’s diarrhoea. J Diarrhoeal Dis Res 1986; 3: 144–8Google Scholar
  72. 72.
    DuPont HL, Ericsson CD, Mathewson JJ, et al. Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico. JAMA 1992; 267: 1932–5PubMedCrossRefGoogle Scholar
  73. 73.
    Navin TR, Juranek DD. Cryptosporidiosis: clinical, epidemiologic, and parisitologic review. Rev Infect Dis 1984; 6: 313–27PubMedCrossRefGoogle Scholar
  74. 74.
    Pitzinger B. Incidence and clinical features of traveler’s diarrhea in infants and children. Pediatr Infect Dis J 1991; 10: 719–23PubMedCrossRefGoogle Scholar
  75. 75.
    Monthly Index of Medical Specialities. London: Haymarket Publishing Services, 1996 Jan: 36–7Google Scholar
  76. 76.
    Behrens RH, Roberts JA. Is travel prophylaxis worthwhile? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers. BMJ 1994; 309: 918–22PubMedCrossRefGoogle Scholar
  77. 77.
    McCormick A. The notification of infectious diseases in England and Wales. Commun Dis Rep CDR Rev 1993; 3: R19PubMedGoogle Scholar
  78. 78.
    Reves RR, Johnson PC, Ericsson CD, et al. Cost-effectiveness comparison of the use of antimicrobial agents for treatment or prophylaxis of travelers’ diarrhea. Arch Intern Med 1988; 148: 2421–7PubMedCrossRefGoogle Scholar
  79. 79.
    West Midlands Compendium of Extra-Contractual Referral Rates. Birmingham: 1995–6Google Scholar
  80. 80.
    Doctors and Dentists Review Body. General medical practitioner’s workload survey 1989–1990. London: Doctors and Dentists Review Body, 1990Google Scholar
  81. 81.
    Department of Employment. Employment Gazette 1993 Jun: S50-4Google Scholar
  82. 82.
    Offices of Population Censuses and Surveys. Communicable diseases statistics 1991. London: Offices of Population Censuses and Surveys, 1991: MB2 No. 18Google Scholar
  83. 83.
    Chemist and Druggist Price List. Chemist Druggist 1991; 32 (10)Google Scholar
  84. 84.
    DuPont HL, Galindo E, Evans DG, et al. Prevention of travelers’ diarrhea with trimethoprim/sulphamethoxazole and trimethoprim alone. Gastroenterology 1983; 84: 75–80PubMedGoogle Scholar

Copyright information

© Adis International Limited 1996

Authors and Affiliations

  • Mike A. Thomson
    • 1
  • Ian W. Booth
    • 1
  1. 1.Institute of Child HealthUniversity of BirminghamBirminghamEngland

Personalised recommendations